Legence Corp. (NASDAQ:LGN) reported mixed results for the fourth quarter on Friday.

The company posted quarterly losses of 55 cents per share which missed the analyst consensus estimate of earnings of 2 cents per share. The company reported quarterly sales of $737.642 million which beat the analyst consensus estimate of $620.307 million.

Legence raised its FY2026 sales guidance from $3.500 billion-$3.700 billion to $3.700 billion-$3.900 billion.

“Our fourth quarter 2025 performance punctuates a milestone year for Legence,” said Jeff Sprau, Chief Executive Officer of Legence. “We achieved record quarterly revenues which increased by 34.6% year over year, driven almost entirely by organic growth. Total backlog and awarded contracts surged by 49% to a record $3.7 billion, led by Data Centers & Technology, along with State & Local Government and Life Science & Healthcare end markets. This exceptional performance is made possible by the dedication of our outstanding team of skilled labor and engineering professionals, who continue to execute at the highest and safest level for our customers.

Legence shares fell 6.1% to trade at $51.39 on Monday.

These analysts made changes to their price targets on Legence following earnings announcement.

  • BMO Capital analyst Devin Dodge maintained Legence with an Outperform rating and raised the price target from $46 to $63.
  • Guggenheim analyst Joseph Osha maintained the stock with a Buy and raised the price target from $68 to $74.

Considering buying LGN stock? Here’s what analysts think:

Photo via Shutterstock